ES2126748T3 - Proceso y compuestos intermedios para la preparacion de inhibidores de la glicoproteina plaquetaria ii b/iii a. - Google Patents

Proceso y compuestos intermedios para la preparacion de inhibidores de la glicoproteina plaquetaria ii b/iii a.

Info

Publication number
ES2126748T3
ES2126748T3 ES94911702T ES94911702T ES2126748T3 ES 2126748 T3 ES2126748 T3 ES 2126748T3 ES 94911702 T ES94911702 T ES 94911702T ES 94911702 T ES94911702 T ES 94911702T ES 2126748 T3 ES2126748 T3 ES 2126748T3
Authority
ES
Spain
Prior art keywords
iii
preparation
intermediate compounds
platelet glycoprotein
glycoprotein inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94911702T
Other languages
English (en)
Inventor
Lin-Hua Zhang
Philip Ma
William Frank Degrado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of ES2126748T3 publication Critical patent/ES2126748T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

EN ESTA INVENCION SE PRESENTAN PROCESOS PARA LA SINTESIS DE INHIBIDORES DE LA GLICOPROTEINA DE PLAQUETAS IIB/IIIA Y COMPUESTOS INTERMEDIOS UTILES EN DICHOS PROCESOS. LOS COMPUESTOS PRESENTADOS EN ESTA INVENCION TIENEN LA FORMULA (I).
ES94911702T 1993-03-29 1994-03-28 Proceso y compuestos intermedios para la preparacion de inhibidores de la glicoproteina plaquetaria ii b/iii a. Expired - Lifetime ES2126748T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3843493A 1993-03-29 1993-03-29

Publications (1)

Publication Number Publication Date
ES2126748T3 true ES2126748T3 (es) 1999-04-01

Family

ID=21899933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94911702T Expired - Lifetime ES2126748T3 (es) 1993-03-29 1994-03-28 Proceso y compuestos intermedios para la preparacion de inhibidores de la glicoproteina plaquetaria ii b/iii a.

Country Status (12)

Country Link
US (1) US5817749A (es)
EP (1) EP0691986B1 (es)
JP (1) JPH08509708A (es)
AT (1) ATE174036T1 (es)
AU (1) AU682857B2 (es)
CA (1) CA2159072A1 (es)
DE (1) DE69415001T2 (es)
DK (1) DK0691986T3 (es)
ES (1) ES2126748T3 (es)
GR (1) GR3029453T3 (es)
NZ (1) NZ263455A (es)
WO (1) WO1994022909A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505555A1 (de) * 1985-02-18 1986-09-11 Behringwerke Ag, 3550 Marburg Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
FR2636066B1 (fr) * 1988-09-02 1991-10-25 Centre Nat Rech Scient Derives de cyclopeptides, utilisables comme inhibiteurs selectifs vis-a-vis de proteases a serine active
JP2945680B2 (ja) * 1988-09-09 1999-09-06 旭硝子株式会社 ペプチド誘導体およびその用途
DD289543A5 (de) * 1989-05-12 1991-05-02 Univ Halle Wittenberg Neue pharmakologisch-aktive cyclopeptide und verfahren zu ihrer herstellung
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
CA2036973A1 (en) * 1990-02-27 1991-08-28 Mark G. Bock Cyclic hexapeptide oxytocin antagonists
US5192746A (en) * 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
EP0540626A1 (en) * 1990-07-24 1993-05-12 Eastman Chemical Company Process for synthesizing peptides
CA2092315A1 (en) * 1990-11-02 1992-05-03 John P. Burnier Platelet aggregation inhibitors
IL103252A (en) * 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SG52262A1 (en) * 1993-01-08 1998-09-28 Tanabe Seiyaku Co Peptide inhibitors of cell adhesion
WO1994022911A2 (en) * 1993-03-29 1994-10-13 The Du Pont Merck Pharmaceutical Company A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE
CA2159070A1 (en) * 1993-03-29 1994-10-13 William Frank Degrado Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia

Also Published As

Publication number Publication date
WO1994022909A1 (en) 1994-10-13
JPH08509708A (ja) 1996-10-15
US5817749A (en) 1998-10-06
AU682857B2 (en) 1997-10-23
DE69415001T2 (de) 1999-05-06
AU6415794A (en) 1994-10-24
DE69415001D1 (de) 1999-01-14
DK0691986T3 (da) 1999-08-16
CA2159072A1 (en) 1994-10-13
GR3029453T3 (en) 1999-05-28
ATE174036T1 (de) 1998-12-15
EP0691986A1 (en) 1996-01-17
NZ263455A (en) 1997-10-24
EP0691986B1 (en) 1998-12-02

Similar Documents

Publication Publication Date Title
FI933568A (fi) 9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
DK0693073T3 (da) Bicykliske ansamyciner og deres anvendelse som antitumormidler
NO932869L (no) 7-(substituerte)-9-((substituerte glycyl)amido)-6-demetyl-6-deoksytetracykliner
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
FI954556A (fi) Syklisiä yhdisteitä, jotka ovat käyttökelpoisia verihiutaleen glykoproteiinin IIb/IIIa inhibiittoreina
MX9302034A (es) Bencidazoles, medicamentos que contienen estos compuestos y procedimientos para su preparacion.
DE69426452T2 (de) Fibrinogen receptor antagonisten
ES2156255T3 (es) Procedimiento para preparar antagonistas del receptor de fibrinogeno.
MX9301298A (es) Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ITMI932056A1 (it) Serratura per contenitori come valigie borse o simili
ES2126748T3 (es) Proceso y compuestos intermedios para la preparacion de inhibidores de la glicoproteina plaquetaria ii b/iii a.
BR9810481A (pt) Processo para preparação de 1h-indol-3-glioxamidas 4-substituìdas.
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
BR9712805A (pt) Processo para a preparação de compostos farmecêuticos
WO1994022911A3 (en) A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE
IT1277680B1 (it) Procedimento per l'alchilazione di composti aromatici
ES2181879T3 (es) Inhibidores de la agkytubacuib de las plaquetas que contienen restos de aminoacidos con cadenas laterales de c-terminal aminergicos.
ES1018141Y (es) "pieza modular para la construccion de forjados"
ECSP972213A (es) Derivados 6,6 o 6,7- biciclicos sustituidos que contienen pirido o pirimido
ECSP972237A (es) Derivados de 6,5 heterobiciclicos sustituidos
ES2142218B1 (es) Composicion de un producto para la conservacion de esmaltes ceramicos y barbotinas.
GR1001368B (el) Φαρμακευτικοί φορείς.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 691986

Country of ref document: ES